Announcements Trials

Browse Landscape

Sponsor

Conditions

Prostatic Neoplasms 4 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Toxemia 1 Stomach Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Primary Ovarian Insufficiency 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Neoplasms 1 Myocarditis 1 Muscle Weakness 1 Melanoma 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Diabetes, Gestational 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Carcinoma, Neuroendocrine 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Bevacizumab 35 durvalumab 23 atezolizumab 22 Nivolumab 20 lenvatinib 19 tremelimumab 16 Specimen Handling 14 Magnetic Resonance Spectroscopy 12 sintilimab 11 pembrolizumab 9 Ipilimumab 9 tislelizumab 7 Sorafenib 7 cabozantinib 5 X-Rays 5 Immunoglobulin G 5 Disulfides 5 Cyclophosphamide 5 regorafenib 4 Radiotherapy 4 Radiosurgery 4 Radiation 4 Oxaliplatin 4 Immunotherapy 4 Ethiodized Oil 4 fludarabine 3 donafenib 3 Surgical Procedures, Operative 3 Folfox protocol 3 Fluorouracil 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Positron-Emission Tomography × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡